Quadrant Capital Group LLC Procept Bio Robotics Corp Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 52 shares of PRCT stock, worth $4,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 28
85.71%
Holding current value
$4,467
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
260Shares Held
38.1MCall Options Held
245KPut Options Held
223K-
Vanguard Group Inc Valley Forge, PA4.84MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$299 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$132 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$107 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$101 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.83B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...